hat tip to Mike Howard… I said, "Carl Elliot, a bioethicist, has mounted a campaign to have this case investigated, so far without success" in the last post [the rightest of causes…]. That doesn’t tell the whole story. They succeeded in getting Dan’s Law passed in the legislature unanimously. And also thanks to Mike Howard, […]
Clinical Efficacy of Reboxetine in Major Depression by Alan F. Schatzberg, M.D. Journal of Clinical Psychiatry. 2000 61[suppl 10]:31–38. The past decade has witnessed the advent of selective serotonin reuptake inhibitors [SSRIs] as first-line treatments for major depression. Still, there is considerable debate as to whether these agents are as effective or as potent as […]
Yes Virginia, there really was a Sigmund Freud. And in his 1900 book, The Interpretation of Dreams, he gave a sample dream of his own he called The Dream of Irma’s Injection which he interprets. And to the delight of students of all kinds over the last century, what Freud doesn’t include in that interpretation […]
Yesterday, I wrote about what we heard about the current goings-on with GSK and Paxil Study 329 [how that should work…, grown-up stuff…]. Today we get yet a new puzzle piece from David Healy – an FDA letter to GSK from 2003 approving Paxil for use in children and adolescents. Yeah, you heard that part […]
In this piece in the British Medical Journal, Peter Doshi summarizes a history that already fills volumes in a short article with supplementary documents. I’ve snipped out some highlights, but I’d suggest reading it in toto. One rarely gets such a full story in such a small place. I’ll jump straight to the punch line. […]
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits Bloomberg By Jef Feeley & David Voreacos Nov 12, 2013 Johnson & Johnson (JNJ) will pay more than $4 billion to resolve thousands of lawsuits over its recalled hip implants in the largest settlement of U.S. legal claims for a medical device, three people […]
Almost two years ago, I went to Austin Texas for the Allen Jones and the State of Texas v. Janssen Trial. At that time, I’d been writing about the psychopharmaceutical industry and its alliances with academic psychiatry for a couple of years, and I’d corresponded some with Allen Jones – the whistle-blower who exposed the […]
We are the hollow men We are the stuffed men Leaning together Headpiece filled with straw. Alas!… T.S. Eliot 1925 Eliot’s Hollow Men expressing his disillusionment with the Europe between the World Wars seems to me a fitting description for the period we’re in with matters psychopharmacologic and psychiatric right now. We’ve been through a […]
Sandra Steingard is the Medical Director of HowardCenter and Clinical Associate Professor of Psychiatry at the University of Vermont College of Medicine in Burlington. She was educated and trained at Harvard and Tufts Universities in Boston and received her specialty certification in psychiatry from the American Board of Psychiatry and Neurology in 1986. She blogs […]
Report Proposes Ways to Expand Access to Clinical Trial Data Harvard Cimson By Emma C. Cobb Oct 30, 2013 Researchers from Harvard, together with members of a group created by the Multi-Regional Clinical Trials Center, released a report last week that proposed ways to expand access to clinical trial data. The report–published online in The […]